A somatic mutation in the 5′UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency

作者: Emanuela Signori , Claudia Bagni , Sara Papa , Beatrice Primerano , Monica Rinaldi

DOI: 10.1038/SJ.ONC.1204620

关键词:

摘要: Mutations in the 5' UTR which cause increment/decrement of translation efficiency have been recently described as a novel molecular mechanism disease. Alterations consensus sequence for initiation may promote context-dependent leaky scanning ribosomes and/or from downstream AUG codon. Initiation in-frame codon BRCA1 gene was identified normal cells and possibly breast cancer. Here we present further insight into translational pathophysiology investigating role canonical structure BRCA1. We analysed effect somatic point mutation (117 G>C) position -3 with respect to gene, highly aggressive sporadic constructed chimeric genes encoding luciferase reporter wild type or mutated 5'UTR. These transcripts were tested their activity vitro vivo systems. In transcription/translation assays estimated construct 5'UTR 30-50% lower than that The same expression by transient transfection human cells. While two constructs equally transcribed, plasmid carrying produced 70% less compared sequence. Finally, obtain direct evaluation on vivo, mRNA translationally active non-active separated transfected Mutant partially localized subpolysomal particles analytically confirming polysome recruitment defect. Thus, characterization seems provide new ovarian cancer pathogenesis.

参考文章(32)
Cindy A. Wilson, Lillian Ramos, Maria R. Villaseñor, Karl H. Anders, Michael F. Press, Kathy Clarke, Beth Karlan, Jun-Jie Chen, Ralph Scully, David Livingston, Robert H. Zuch, Michael H. Kanter, Sylvan Cohen, Frank J. Calzone, Dennis J. Slamon, Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas Nature Genetics. ,vol. 21, pp. 236- 240 ,(1999) , 10.1038/6029
Béatrice Conne, André Stutz, Jean-Dominique Vassalli, The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology? Nature Medicine. ,vol. 6, pp. 637- 641 ,(2000) , 10.1038/76211
CI Szabo, MC King, Inherited breast and ovarian cancer Human Molecular Genetics. ,vol. 4, pp. 1811- 1817 ,(1995) , 10.1093/HMG/4.SUPPL_1.1811
Ui-Soon Khoo, Hilmi Ozcelik, Annie NY Cheung, Louis WC Chow, Hextan YS Ngan, Susan J Done, A C T Liang, Vivian WY Chan, Gordon KH Au, Wing-Fung Ng, Cycles SP Poon, Yuet-Foon Leung, Florence Loong, Philip Ip, Gavin SW Chan, Irene L Andrulis, Jing Lu, Faith CS Ho, Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer Oncogene. ,vol. 18, pp. 4643- 4646 ,(1999) , 10.1038/SJ.ONC.1202847
Elizabeth M Jarvis, Judy A Kirk, Christine L Clarke, Loss of Nuclear BRCA1 Expression in Breast Cancers Is Associated with a Highly Proliferative Tumor Phenotype Cancer Genetics and Cytogenetics. ,vol. 101, pp. 109- 115 ,(1998) , 10.1016/S0165-4608(97)00267-7
Marilyn E. Thompson, Roy A. Jensen, Patrice S. Obermiller, David L. Page, Jeffrey T. Holt, Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression Nature Genetics. ,vol. 9, pp. 444- 450 ,(1995) , 10.1038/NG0495-444
Liam T. Seery, Janice M. Knowlden, Julia M.W. Gee, John F.R. Robertson, Francis S. Kenny, Ian O. Ellis, Robert I. Nicholson, BRCA1 expression levels predict distant metastasis of sporadic breast cancers. International Journal of Cancer. ,vol. 84, pp. 258- 262 ,(1999) , 10.1002/(SICI)1097-0215(19990621)84:3<258::AID-IJC10>3.0.CO;2-H